Entropy Technologies’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.29M Buy
+14,310
New +$837K 0.04% 526
2025
Q3
– Sell
-30,617
Closed -$355K – 1098
2025
Q2
$355K Buy
+30,617
New +$279K 0.03% 569
2025
Q1
– Sell
-37,595
Closed -$540K – 989
2024
Q4
$540K Buy
37,595
+27,844
+286% +$439K 0.06% 418
2024
Q3
$220K Sell
9,751
-12,974
-57% -$268K 0.02% 618
2024
Q2
$442K Sell
22,725
-3,747
-14% -$98.1K 0.05% 422
2024
Q1
$993K Buy
+26,472
New +$1.16M 0.11% 287

Other funds holding TXG

Entropy Technologies's TXG Position: Q3 2026 in Review

Entropy Technologies opened a new position in 10x Genomics (TXG) in Q3 2026: 14,310 shares worth $1.29M. The stake represents 0.04% of the portfolio and ranks #526 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in TXG as recently as Q2 2025.

Entropy Technologies first reported a position in TXG in Q1 2024 and has held it in 6 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Entropy Technologies held 14,310 shares of 10x Genomics worth $1.29M as of Q3 2026.
  • 10x Genomics was a new Entropy Technologies position in Q3 2026.
  • 10x Genomics made up 0.04% of Entropy Technologies's portfolio in Q3 2026, its #526 holding.
  • Entropy Technologies first reported a position in 10x Genomics in Q1 2024 and has held it in 6 quarters since.
  • 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Entropy Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.